Back to Authors

Tanvir, Imran

Mayo Clinic

Alexion Pharmaceuticals (United States)

Citations 2

Benefit of Eculizumab for a Broad Range of Patients with Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: Findings from the Phase 3 PREVENT Study (1299)
Kim, Ho Jin , Terzi, Murat , Wang, Kaichen , Pace, Amy , Yountz, Marcus, Miller, Larisa , Tanvir, Imran, Armstrong, Róisín, Wingerchuk, Dean M. , Fujihara, Kazuo , Berthele, Achim , Levy, Michael , Nakashima, Ichiro , Oreja‐Guevara, Celia , Palace, Jacqueline , Pittock, Sean J. , Totolyan, N. А. , Viswanathan, Shanthi

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.1299 Get It

Indirect Comparison Analysis of FDA-Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder (P15-1.007)
Wingerchuk, Dean M. , Kielhorn, Adrian , Royston, Minying , Tanvir, Imran, Zhang, Ina, Pittock, Sean J. , Levy, Michael , Fujihara, Kazuo , Nakashima, Ichiro , Paul, Friedemann

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.1618 Get It